This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.
To read this article, please click here.
More RSI News
Best Practices for Consideration of the Effects of Climate Change in Project-Level Assessments
Risk Sciences International (RSI) is pleased to announce in collaboration with the Ontario Centre for Climate Impacts and Adaptation Resources (OCCIAR), the public release of…
Risks of anticholinergic drugs
Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records…
Dr. Emma Hartnett Selected for JEMRA Roster of Scientific Experts
RSI’s Emma Hartnett has been selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts for a…
Safety Profiles of Newer Contraceptives presented at meeting of Society of Reproductive Investigation
RSI Chief Medical Officer, Dr. Donald R. Mattison, in collaboration with colleagues from the Institute for Safe Medication Practices and Wake Forest University, evaluated and…